What is Invokana and Why is it Prescribed by Physicians?
Invokana and similar medications are a particular type of diabetes medications called SGLT2 inhibitors. They are prescribed for adults with type 2 diabetes to lower blood sugar and improve glycemic control. SGLT2 inhibitors are intended to lower a person’s blood sugar by causing the kidneys to remove sugar from the bloodstream through urine, but this is not the body’s natural method of sugar level regulation.
What Other Medications are Included in the Invokana Lawsuits?
SGLT2 inhibitors are marketed under several names, including Invokana (canagliflozin), Glyxambi (empagliflozin/linagliptin), Invokamet (canagliflozin/metformin), Xigduo XR (dapagliflozin/metformin), Jardiance (empagliflozin), and Farxiga (dapagliflozin)
Why are There Invokana Lawsuits?
SGLT2 inhibitors represent a substantial change in the treatment of Type 2 diabetes. The Invokana lawsuits allege that Invokana’s manufacturer failed to warn patients and physicians of the increased risks of ketoacidosis, kidney failure, and heart attacks that may result from taking the medication. Patients filing these lawsuits allege that, if Invokana’s manufacturer had properly warned of the risks, patients would have been prescribed a different medication for their diabetes or would have had more frequent physician monitoring for an elevated level of ketones or developing heart issues. Unfortunately, many patients are suffering catastrophic damage and sometimes death because of these undetected health problems.
Has the FDA Recalled the Medication?
There has been no FDA recall of Invokana or other SGLT2 inhibitors, but in May, 2015, the FDA issued a warning that the use of Invokana and Invokamet may lead to diabetic ketoacidosis. In December, 2015, the FDA required the manufacturers to update their labels to warn of the risk of ketoacidosis and urinary tract infections.
What Should I Do Now?
Everyone living with diabetes should try to live a lifestyle that is as healthy as possible. A proper diet, exercise, and abstinence from alcohol will all promote healthier living for diabetics. If you were prescribed Invokana or another SGLT and suffered diabetic ketoacidosis or heart failure, however, our lawyers want to hear from you. You may be able to hold the manufacturer of the medication responsible for your harms and losses, which could have been avoided with appropriate warnings from the manufacturer.